CRISPR Therapeutics AG’s recently made public that its Chief Medical Officer Patel Naimish unloaded Company’s shares for reported $0.14 million
In a filing, CRISPR Therapeutics AG revealed its Chief Medical Officer Patel Naimish unloaded Company’s shares for reported $0.14 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
CRISPR Therapeutics AG’s recently made public that its Chief Medical Officer Patel Naimish unloaded Company’s shares for reported $0.14 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or